These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 2890309)
1. Follow-up study of 11 patients with potentially reversible tardive dyskinesia. Yagi G; Itoh H Am J Psychiatry; 1987 Nov; 144(11):1496-8. PubMed ID: 2890309 [TBL] [Abstract][Full Text] [Related]
2. Clinical forms of severe tardive dyskinesia. Gardos G; Cole JO; Salomon M; Schniebolk S Am J Psychiatry; 1987 Jul; 144(7):895-902. PubMed ID: 2886062 [TBL] [Abstract][Full Text] [Related]
3. Comparison of severe and mild tardive dyskinesia: implications for etiology. Gardos G; Cole JO; Schniebolk S; Salomon M J Clin Psychiatry; 1987 Sep; 48(9):359-62. PubMed ID: 2887550 [TBL] [Abstract][Full Text] [Related]
4. Prevention and management of tardive dyskinesia. Jeste DV; Wyatt RJ J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):14-8. PubMed ID: 2858473 [TBL] [Abstract][Full Text] [Related]
5. Ten-year outcome of tardive dyskinesia. Gardos G; Casey DE; Cole JO; Perenyi A; Kocsis E; Arato M; Samson JA; Conley C Am J Psychiatry; 1994 Jun; 151(6):836-41. PubMed ID: 7910437 [TBL] [Abstract][Full Text] [Related]
6. Factors in the development of severe forms of tardive dyskinesia. Yassa R; Nair NP; Iskander H; Schwartz G Am J Psychiatry; 1990 Sep; 147(9):1156-63. PubMed ID: 1974745 [TBL] [Abstract][Full Text] [Related]
7. Tardive dyskinesia--reversible and persistent. Jeste DV; Potkin SG; Sinha S; Feder S; Wyatt RJ Arch Gen Psychiatry; 1979 May; 36(5):585-90. PubMed ID: 35116 [TBL] [Abstract][Full Text] [Related]
11. [Occurrence of tardive dyskinesia during neuroleptic treatment]. Fanget F; Henry E; Aimard G Presse Med; 1986 Dec; 15(43):2147-50. PubMed ID: 2884657 [TBL] [Abstract][Full Text] [Related]
12. Neuroleptic drugs: how to reduce the risk of tardive dyskinesia. DeVeaugh-Geiss J Geriatrics; 1979 Jul; 34(7):59-61, 66. PubMed ID: 36330 [TBL] [Abstract][Full Text] [Related]
13. A review of 32 cases of tardive dystonia. Wojcik JD; Falk WE; Fink JS; Cole JO; Gelenberg AJ Am J Psychiatry; 1991 Aug; 148(8):1055-9. PubMed ID: 1677236 [TBL] [Abstract][Full Text] [Related]
14. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia. Sirota P; Mosheva T; Shabtay H; Giladi N; Korczyn AD Am J Psychiatry; 2000 Feb; 157(2):287-9. PubMed ID: 10671405 [TBL] [Abstract][Full Text] [Related]
15. Does clozapine cause tardive dyskinesia? Kane JM; Woerner MG; Pollack S; Safferman AZ; Lieberman JA J Clin Psychiatry; 1993 Sep; 54(9):327-30. PubMed ID: 8104929 [TBL] [Abstract][Full Text] [Related]
16. The prevalence of tardive dyskinesia in neuroleptic-treated diabetics. A controlled study. Ganzini L; Heintz RT; Hoffman WF; Casey DE Arch Gen Psychiatry; 1991 Mar; 48(3):259-63. PubMed ID: 1671743 [TBL] [Abstract][Full Text] [Related]